Jasper Therapeutics, Inc. · NASDAQ:JSPR

Integrated Core Strategies (US) LLC reported a 5.80% stake in Jasper Therapeutics, Inc. (Schedule 13G)

Event Feb 18, 2026 · Filed Feb 25, 2026

Integrated Core Strategies (US) LLC reported a 5.80% stake in Jasper Therapeutics, Inc., 1,624,076 shares, as a passive investor on Feb 18, 2026. Filed Feb 25, 2026 (Schedule 13G).

Stake
5.80%
Shares
1,624,076
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Integrated Core Strategies (US) LLC5.80%1,624,076
Millennium Management LLC5.80%1,629,013
Millennium Group Management LLC5.80%1,629,013
Israel A. Englander5.80%1,629,013

Source

View original at SEC

Related